In our country, the high incidence of heart-borne shock is due to the fact that the extreme loss of heart function has led to a reduction in heart drains, the failure to meet the acute syndrome of the surrounding cycle, which can endanger life in a short period of time, requiring timely identification of the disease and active and effective treatment to save life. However, there are some similarities between heart-borne shock and shock symptoms caused by a variety of factors, which may lead to misdiagnosis, and the clinical identification and treatment of heart-borne shock is described below.
Clinical recognition of heart-borne shock
1.1 Clinical symptomsSymptoms such as cardiac cramps, pale skin, disillusionment, weak pulses, accelerated heart rate, etc. generally suggest the possibility of a heart-borne shock, which can be initially diagnosed by a physician.1.2 CausesThe high incidence of shock, which can be caused by infections, allergies, low capacity, etc., and the fact that heart-borne shock is mainly caused by cardiac dysfunction, can be used to identify heart-borne shock by examining visible cases of myocardia and reduced heart discharges.1.3 Clinical examination(1) EKG: The EKG is the primary method for the diagnosis of heart-borne shock and can detect the causes of heart-borne shock such as cardiac disorders and myocardial infarction.(2) Blood flow mechanics monitoring, which includes the monitoring of indicators such as central intravenous pressure, blood pressure, urine, etc., allows direct observation of the heart pump function of the patient to facilitate clinical determination of whether the patient is heart-borne.(3) Blood examination: e.g. myocardial enzyme, calcium protein, etc., assesses the extent to which the heart of the patient has been damaged in order to understand the heart of the patient and to identify whether it is heart-borne shock.(4) Heart Ultrasound: The state of the heart structure and function is known through ultrasound, and the clinical can identify heart changes based on changes in the heart structure and function, and identify heart-borne shock.(5) Coronary Artemisynthesis: For patients suspected of cardiac infarction leading to a heart-borne shock, coronary artery vilification may be performed to determine whether coronary artery pathologies exist.2. Clinical treatment for heart-borne shock2.1 Blood flow mechanics supportIn the case of heart-borne shock treatment, hemodynamic support is the basic programme for the treatment of heart-borne shock, which can be divided into rehydration, the use of vascular active drugs and mechanical aids.The rehydration can correct the low blood capacity, improve tissue infusion and help to restore blood flow.Angiologically active drugs such as dopamine, detorenalin, etc. can increase blood pressure, maintain tissue injections and restore heart pump blood function.Mechanical aids such as an acoustic cystal repulsion IABP and an epidural pulmonary oxidation ECMO can reduce the heart burden and improve the heart function.2.2 Active treatment of primary diseasesIn order to achieve a cure, the treatment should be tailored to the main cause of the heart-borne shock of the patient and promote post-treatment rehabilitation.Acute myocardial infarction patients should be treated with coronary artery intervention as soon as possible to restore coronary blood flow; heart valve patients should undergo valor replacement or repair surgery; and cardiac patients should be treated for myocardiosis, such as the use of beta-receptor retardants, formaldecodone receptors, etc.2.3 Drug treatmentHeart-borne shock is mainly caused by cardiac disorders, and therefore, in addition to the necessary conventional hemodynamic support and treatment of the disease, medication should be used for long periods of time to stabilize the condition, including positive mystic drugs such as dobarolbutamide, miricon, urea such as fursemi, Torasemi etc., angiogenesis such as nitro sodium, anticondens such as hepatin, Wafarin, etc.These can improve heart function, correct sodium sodium in water, reduce pre- and post-heart loads and prevent haemobation.2.4 Active prevention of complicationsThere are a number of complications that may arise in some of the patients following a heart-borne shock, including kidney failure, infection, electrolytic disorders, which have serious consequences for the recovery and physical health of the patient and should therefore be actively prevented in the treatment of heart-borne shock.Doctors are required to closely monitor the patient ‘ s infection indicators and to provide timely anti-infection treatment; to take care to protect the kidney function from the use of renal toxicity drugs; and to correct electrolyte disorders and maintain internal environmental stability.2.5 SurgerySurgery provides rapid treatment for pre-emergence diseases and stabilizes conditions, such as acoustic cystal repulsion, heart transplants, artificial heart, etc., and is generally used primarily for patients with severe hemodynamic disorders (acute myocardial infarction complications, stubborn pulmonary oedema, etc.).The post-operative survival rate can be improved effectively through the surgical programme; however, there may be associated complications following the heart transplant, the effect of which is to be seen in the clinical context, and the clinical choice of treatment based on the patient ‘ s actual situation.SummaryHeart-borne shock is progressing at a relatively rapid pace, usually within 24h of the patient ‘ s onset. As a result, patients should be identified and treated in a timely and untimely manner, and should actively cooperate with doctors in order to identify the type of disease, save as much as possible the patient ‘ s life and increase survival.
